858 — Extrawell Pharmaceutical Holdings Share Price
0.000.00%
Last trade - 00:00- HK$66.92m
- HK$85.60m
- HK$72.58m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.06 | ||
| Price to Tang. Book | 0.06 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.98 | ||
| EV to EBITDA | 54.32 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -11.32% | ||
| Return on Equity | -13.78% | ||
| Operating Margin | -190.33% | ||
Financial Summary
| Year End 31st Mar | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | HK$m | 89.22 | 77.58 | 78.8 | 73.92 | 72.58 | n/a | n/a | -3.28% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +44.75 | +27.52 | n/a | n/a | +0.66 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Extrawell Pharmaceutical Holdings Ltd is an investment holding company principally engaged in the development, manufacture and sale of pharmaceuticals. The Company operates its business through three segments. The Manufacturing segment is engaged in the development, manufacture and sales of pharmaceutical products. Its self-produced products include Transfer Factor Oral Solution, Wisk, ZhouBang and others. The Trading segment is engaged in the promotion and distribution of imported pharmaceuticals. Its imported products include Millibar and Skin Cap. The Gene Development segment is engaged in the commercial development and research, development of gene-related technologies.
Directors
- Yi Xie CHM (51)
- Lian Bang Chan GMG (59)
- Kwok Wah Liu CTR (52)
- Sau Kuen Wong EDR (51)
- Yong Cheng EDR (51)
- Yi Lou EDR (55)
- Ming Wen OTH (53)
- Hong Wu OTH (42)
- Lin Hu Fang NID (76)
- Song Jin NID (43)
- Jing Lun Xue NID (80)
- Last Annual
- March 31st, 2023
- Last Interim
- September 30th, 2023
- Incorporated
- December 8th, 1998
- Public Since
- March 10th, 1999
- No. of Employees
- 169
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 2,390,000,000
- Address
- Suites 2206-08, 22nd Floor, Devon House,
- Web
- http://www.extrawell.com.hk
- Phone
- +852 null28561918
- Auditors
- Elite Partners CPA Limited
Upcoming Events for 858
Similar to 858
3D Medicines
Stock Exchange of Hong Kong Limited
3SBio
Stock Exchange of Hong Kong Limited
AIM Vaccine Co
Stock Exchange of Hong Kong Limited
Ascletis Pharma
Stock Exchange of Hong Kong Limited
Asymchem Laboratories Tianjin Co
Stock Exchange of Hong Kong Limited
FAQ
What is the Extrawell Pharmaceutical Holdings share price?
As of Today at 19:08 UTC, shares in Extrawell Pharmaceutical Holdings are trading at HK$0.03. This share price information is delayed by 15 minutes.
How has the Extrawell Pharmaceutical Holdings share price performed this year?
Shares in Extrawell Pharmaceutical Holdings last closed at HK$0.03 and the price had moved by -56.92% over the past 365 days. In terms of relative price strength the Extrawell Pharmaceutical Holdings share price has underperformed the FTSE Developed Asia Pacific Index by -55.04% over the past year.
What are the analyst and broker recommendations for Extrawell Pharmaceutical Holdings?
There is no consensus recommendation for this security.
What is the Extrawell Pharmaceutical Holdings dividend yield?
Extrawell Pharmaceutical Holdings does not currently pay a dividend.
Does Extrawell Pharmaceutical Holdings pay a dividend?
Extrawell Pharmaceutical Holdings does not currently pay a dividend.
When does Extrawell Pharmaceutical Holdings next pay dividends?
Extrawell Pharmaceutical Holdings does not currently pay a dividend.
How do I buy Extrawell Pharmaceutical Holdings shares?
To buy shares in Extrawell Pharmaceutical Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Extrawell Pharmaceutical Holdings?
As of the previous close price of HK$0.03, shares in Extrawell Pharmaceutical Holdings had a market capitalisation of HK$66.92m.
Where are Extrawell Pharmaceutical Holdings shares listed?
Here are the trading details for Extrawell Pharmaceutical Holdings:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 858
What kind of share is Extrawell Pharmaceutical Holdings?
Based on an overall assessment of its quality, value and momentum Extrawell Pharmaceutical Holdings is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Extrawell Pharmaceutical Holdings share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Extrawell Pharmaceutical Holdings share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Extrawell Pharmaceutical Holdings. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -44.19%.
As of the last closing price of HK$0.03, shares in Extrawell Pharmaceutical Holdings were trading -30.87% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Extrawell Pharmaceutical Holdings PE Ratio?
The Extrawell Pharmaceutical Holdings PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$0.03.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Extrawell Pharmaceutical Holdings?
Extrawell Pharmaceutical Holdings' management team is headed by:
- Yi Xie - CHM
- Lian Bang Chan - GMG
- Kwok Wah Liu - CTR
- Sau Kuen Wong - EDR
- Yong Cheng - EDR
- Yi Lou - EDR
- Ming Wen - OTH
- Hong Wu - OTH
- Lin Hu Fang - NID
- Song Jin - NID
- Jing Lun Xue - NID